Robert Rolleri
Publications by Year
Research Areas
Hidradenitis Suppurativa and Treatments, Colorectal and Anal Carcinomas, Chemotherapy-related skin toxicity, Microscopic Colitis, Inflammatory Bowel Disease
Most-Cited Works
- → A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity(2014)229 cited
- → Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa(2021)160 cited
- → Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials(2024)137 cited
- → Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT)(2018)130 cited
- → Budesonide Foam Induces Remission in Patients With Mild to Moderate Ulcerative Proctitis and Ulcerative Proctosigmoiditis(2015)105 cited
- → Certolizumab pegol for the treatment of patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials(2018)38 cited
- → Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis(2015)18 cited
- → Validation of the Hidradenitis Suppurativa Investigator Global Assessment(2023)17 cited
- → Dose Proportionality and the Effects of Food on Bioavailability of an Immediate-Release Oxycodone Hydrochloride Tablet Designed to Discourage Tampering and Its Relative Bioavailability Compared With a Marketed Oxycodone Tablet Under Fed Conditions: A Single-Dose, Randomized, Open-Label, 5-Way Crossover Study in Healthy Volunteers(2012)11 cited
- → Assessing subjective and physiologic effects following intranasal administration of a new formulation of immediate release oxycodone HCl (Oxecta™) tablets in nondependent recreational opioid users(2012)9 cited